CD20 & CD22
Loading...Anti-CD20 & CD22 Products
+ Filter
Loading...- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Compare
- Mouse Anti-Human CD22 Recombinant Antibody (TAB-003LC)
-
- Application: FC
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1717CL) (TAB-1717CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1718CL) (TAB-1718CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1719CL) (TAB-1719CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1720CL) (TAB-1720CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1721CL) (TAB-1721CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
- Mouse Anti-CD22 Recombinant Antibody (clone AB008) (HPAB-0709-FY)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA
Compare
- Mouse Anti-CD22 Recombinant Antibody (TAB-005LC) (TAB-005LC)
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: FC, Cyt, Block, Apop, ROS assay, FuncS
Compare
- Human Anti-CD22 Antibody (clone g5/44), mRNA (FAMAB-0047YC-mRNA)
-
- Species Reactivity: Human
Compare
- Human Anti-CD22 Recombinant Antibody (clone LL2 (EPB2)) (FAMAB-1042CQ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: RIA, FC, IHC
Compare
- Mouse Anti-CD22 Antibody (clone m5/44), mRNA (FAMAB-0046YC-mRNA)
-
- Species Reactivity: Human
Compare
- Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1729CL-S(P)) (TAB-1729CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: IF, FC
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-001LC-S(P)) (TAB-001LC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
Compare
- Human Anti-CD22 Recombinant Antibody (HPAB-0195-LSX) (HPAB-0195-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: Apop, Cyt, FC, WB, Inhib, FuncS, IF, ELISA
Compare
-
- Derivation: Rabbit
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, FC, WB, IF
Compare
- Human Anti-CD22 Antibody, mRNA (HPAB-0249-FY-mRNA)
-
- Species Reactivity: Human
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (VM1000) (TAB-002LC-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: ELISA, SPR
Compare
- Human Anti-CD22 Recombinant Antibody (clone To15) (FAMAB-1041CQ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: Adhesion, FACS, IP, IHC
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1715CL) (TAB-1715CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1716CL) (TAB-1716CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1715CL-S(P)) (TAB-1715CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-001LC) (TAB-001LC)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
Compare
- Anti-Human CD22 Recombinant Antibody (VM1000) (TAB-002LC)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA, SPR, FuncS
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1724CL-S(P)) (TAB-1724CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
Compare
- Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1725CL-S(P)) (TAB-1725CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Block, Cyt, ELISA, FuncS
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Application: IF, IP, Neut, FuncS, ELISA, FC
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Application: ELISA, FC, IP, FuncS, IF, Neut
Compare
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1715CL-F(E)) (TAB-1715CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
-
- Application: ELISA, In vivo
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2-Cys) (TAB-0197CL-S(P))
-
- Application: ELISA, In vivo
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1716CL-S(P)) (TAB-1716CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1717CL-S(P)) (TAB-1717CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1718CL-S(P)) (TAB-1718CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1719CL-S(P)) (TAB-1719CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1720CL-S(P)) (TAB-1720CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1721CL-S(P)) (TAB-1721CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1722CL-S(P)) (TAB-1722CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-Sap (AGTO-G077S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1723CL-S(P)) (TAB-1723CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1714CL-S(P)) (TAB-1714CL-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
Compare
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
Compare
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
Compare
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
Compare
- Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (HPAB-1903LY-S(P)) (HPAB-1903LY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, Inhib
Compare
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (HPAB-1899LY-S(P)) (HPAB-1899LY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, Inhib
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (HPAB-1900LY-S(P)) (HPAB-1900LY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, Inhib
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (HPAB-1901LY-S(P)) (HPAB-1901LY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, Inhib
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (HPAB-1902LY-S(P)) (HPAB-1902LY-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, Inhib
Compare
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (HPAB-N0324-YC-F(E)) (HPAB-N0324-YC-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FuncS
Compare
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (HPAB-N0325-YC-F(E)) (HPAB-N0325-YC-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FuncS
Compare
- Anti-Human CD22 Recombinant Antibody (TAB-004LC)
-
- Application: FC
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (RFB4) (TAB-1728CL-S(P))
-
- Application: IF, FC
Compare
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
Compare
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
Compare
- Anti-CD22 (clone 10F4v1)-MC-MMAF ADC (ADC-229CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-228CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone RFB4)-SMCC-DM1 ADC (ADC-224CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAF ADC (ADC-225CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAE ADC (ADC-227CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone RFB4)-MC-MMAF ADC (ADC-226CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: IP, WB
Compare
- Anti-CD22 (clone 5E8)-SMCC-DM1 ADC (ADC-214CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 7A2)-SMCC-DM1 ADC (ADC-215CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v1)-SMCC-DM1 ADC (ADC-216CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v2)-SMCC-DM1 ADC (ADC-217CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v2)-MC-MMAF ADC (ADC-218CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-SMCC-DM1 ADC (ADC-219CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-220CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-221CL)
-
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-222CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (ADC-223CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
Compare
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
Compare
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
Compare
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
Compare
- Anti-CD22 (clone 10F4v3)-MCC-DM1 ADC (ADC-194LZY)
-
- Target: CD22
- Linker: MCC(Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-mc-vc-PABC-MMAE ADC (ADC-195LZY)
-
- Target: CD22
- Linker: mc-VC-PABC(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
Compare
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
Compare
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome.
CD20 is a cell surface protein expressed on B cells. It is a common target for monoclonal antibody therapy in B-cell lymphomas and autoimmune diseases.